Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study Juan Carlos CervellinoCarlos E. AraujoRodolfo Rossi Ifosfamide, Mesna, Cervical Cancer Pages: S1 - S3
A phase II study of ifosfamide in endometrial cancer C. BartonE. J. BuxtonC. A. Meanwell Ifosfamide, Endometrial Cancer Pages: S4 - S6
Preclinical phase II study of ifosfamide in human tumour xenografts in vivo D. P. BergerH. H. FiebigH. Henss Ifosfamide, Human Tumour Xenografts Pages: S7 - S11
Phase II studies of ifosfamide alone and in combination in cancer of the cervix G. BlackledgeE. J. BuxtonC. A. Meanwell Ifosfamide, Cisplatin, Bleomycin, Cervical Cancer Pages: S12 - S16
The potential for adjuvant therapy in early-stage cervical cancer E. J. BuxtonN. SaundersD. M. Luesley Adjuvant Therapy, Early-Stage Cervical Cancer Pages: S17 - S21
Dose intensity of carboplatin in combination with cyclophosphamide or ifosfamide John A. GreenKathyryn Smith Ifosfamide, Carboplatin, Cyclophosphamide, Ovarian Cancer Pages: S22 - S25
Ifosfamide with and without Adriamycin in advanced uterine leiomyosarcoma Robert E. HawkinsEve WiltshawJanine L. Mansi Ifosfamide, Adriamycin, Uterine Leiomyosarcoma Pages: S26 - S29
The role of chemotherapy including ifosfamide for ovarian carcinoma K. KarrerH. SalzerAustrian Collab. Ovarian Cancer Study Group Ifosfamide, Chemotherapy, Ovarian Carcinoma Pages: S30 - S32
Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer H. KühnleH. G. MeerpohlW. Achterrath Carboplatin/Ifosfamide Advanced Cervical Cancer Pages: S33 - S35
Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma Pedro C. LaraJose L. Garcia-PucheVicente Pedraza Cisplatin-Ifosfamide, Neoadjuvant Chemotherapy, Uterine Squamous-Cell Carcinoma Pages: S36 - S38
Treatment of gynecological malignancies with a combination of cisplatin, Adriamycin and ifosfamide Takashi NishidaNaoki NagasueMichiaki Yakushiji Ifosfamide, Adriamycin, Cisplatin, Gynecological Malignancies Pages: S39 - S42
Timed sequential chemotherapy following ifosfamide-induced kinetic recruitment in refractory ovarian cancer R. RossoA. AlamaP. F. Conte Ifosfamide, Chemotherapy, Ovarian Cancer Pages: S43 - S44
A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas Claes TropéJanne KærnSvein Vossli Ifosfamide, Etoposide, Cisplatin Tesistance, Ovarian Carcinoma Pages: S45 - S47
Carboplatin and ifosfamide in ovarian cancer phase II and III trials E. WiltshawT. J. PerrenLondon Gynaecological Oncology Group Ifosfamide, Carboplatin, Ovarian Cancer Pages: S48 - S50
Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results P. H. B. WillemseM. E. L. v. d. BurgE. G. E. de Vries Ifosfamide, Mesna, Recurrent Ovarian Cancer Pages: S51 - S54
Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies Gregory P. SuttonJohn A. BlessingHoward D. Homesley Ifosfamide/Mesna, Gynecologic Malignancies Pages: S55 - S58
Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer J. TobiasE. J. BuxtonA. Chetiyawardana Ifosfamide, Cisplatin, Bleomycin, Cervical Cancer Pages: S59 - S62
Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer R. ParidaensC. FocanM. T'Hooft-Andry Ifosfamide, Mesna, Advanced Breast Cancer Pages: S63 - S65
Treatment of metastatic breast cancer with the combination of ifosfamide, epirubicin and 5-fluorouracil A. Ghavamzadeh Ifosfamide, Epirubicin, 5-Fluorouracil, Metastatic Breast Cancer Pages: S66 - S68
Epirubicin and ifosfamide in patients with refractory breast cancer and other metastatic solid tumours W. HoffmannB. WeidmannS. Seeber Ifosfamide, Epirubicin, Refractory Breast Cancer, Metastatic Solid Tumours Pages: S69 - S70
Ifosfamide combination chemotherapy in advanced breast cancer Hans SchmidManfred KaufmannGunther Bastert Ifosfamide, Chemotherapy, Advanced Breast Cancer Pages: S71 - S73
Palliative chemo-radiotherapy with ifosfamide and epirubicin as first-line treatment for high-risk metastatic breast cancer O. F. LangeW. ScheefG. Zegners Ifosfamide, Epirubicin, Chemo-Radiotherapy, Metastatic Breast Cancer Pages: S74 - S77
Palliative radio-chemotherapy with ifosfamide and BCNU for breast cancer patients with cerebral metastases O. F. LangeW. ScheefK. D. Haase Ifosfamide, BCNU, Radio-Chemotherapy, Breast Cancer, Cerebral Metastases Pages: S78 - S80
Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclines Joaquin BellmuntSerafin MoralesLuis-Alfonso Solé Ifosfamide/Mitoxantrone, Anthracyclines, Advanced Breast Cancer Pages: S81 - S84
Ifosfamide, methotrexate, and 5-fluorouracil: effective combination in resistant breast cancer N. Gad-El-MawlaM. R. HamzaR. Gafaar Ifosfamide, Methotrexate, 5-Fluorouracil, Resistant Breast Cancer Pages: S85 - S86
Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer Christian ManegoldPeter WorstManfred Kaufmann Ifosfamide/Etoposide, Mesna, Uroprotection, Advanced Breast Cancer Pages: S87 - S90
High-dose ifosfamide and mesna in advanced breast cancer F. SanchizA. Milla High-Dose Ifosfamide, Mesna, Advanced Breast Cancer Pages: S91 - S92
A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer T. LangenbuchK. MrossD. K. Hossfeld High-Dose Ifosfamide, Epirubicin/Verapamil, Advanced Breast Cancer Pages: S93 - S96
Discussion at the Satellite symposium: Ifosfamide in gynecological tumors E. WiltshawA. PfleidererH. T. Mouridsen Ifosfamide, Gynecological Tumours Pages: S97 - S101